To further develop understanding of the current and future world of work to ensure that our regulatory approach remains suitable and sufficient, including where our regulatory interests extend beyond preventing harm to workers, e.g. covering assessment of potential adverse impacts of chemicals on the general public, consumers and the environment. To equip ourselves with new insights into the reasons why particular failures in health and safety occur. To develop the existing system of ongoing data collection, analysis, interpretation and result dissemination so that it continues to support HSE’s current priorities and prevention strategies and is flexible enough to adapt to change. To identify health and safety hazards and risks arising from change in the GB workforce and their work.
Get in touch with hsecsa@hse.gov.uk
This question was published as part of the set of ARIs in this document:
Engineering and manufacturing companies need to have flexible but consistent regulations to be able to co-create and collaborate effectively. Sharing data and decisions in a safe and effective way across extended supply ...
Funded by: Innovate UK
Lead research organisation: NPL MANAGEMENT LIMITED
The project focuses on developing regulations for effective governance in complex supply chains involving industry and academia, aligning with the question's emphasis on accountability and joined-up approaches with experts.
AI is revolutionising many areas. However, with the increasing use of AI, there are growing concerns surrounding the reliability, risks and ethics of AI powered decision-making processes, and the potential harm it can le...
Funded by: Innovate UK
Lead research organisation: HUMBLE AI LIMITED
The project partially addresses the question by developing an AI system that provides transparency, accountability, and reliability in decision-making, but does not specifically address governance through complex AI supply chains or encourage joined-up approaches with AI/digital experts.
In order to meet National and International medicines demand, both small and large pharmaceutical companies need to use multiple suppliers. It takes significant effort to coordinate these separate companies and create an...
Funded by: ISCF
Lead research organisation: GSK LIMITED
The project partially answers the question by discussing the application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainability. The authors have the necessary expertise to competently answer the question.